Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation (NCT07292584)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to test if a Digital PrEP Toolkit helps cisgender women learn about and access PrEP in Alabama and Mississippi. PrEP is a medication that prevents HIV infection. The main questions it aims to answer are: Can participants complete the Digital PrEP Toolkit in under 10 minutes? Do participants find the Digital PrEP Toolkit useful and easy to use? Does the Digital PrEP Toolkit increase the number of women who start taking PrEP? Investigators will work with up to 125 women at 3 HIV and STI clinics in Alabama and Mississippi. Participants will use the Digital PrEP Toolkit on a tablet at the clinic. They will answer questions about their HIV knowledge before and after using the Toolkit. Participants will then discuss PrEP options with a healthcare staff member and decide if they want to start PrEP. Participants will answer follow-up questions at 3 months. Investigators will also review participants' medical records at 6 months to see if they started PrEP and are still taking it.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
- Interactive Digital PrEP Toolkit (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- University of Alabama at Birmingham — Birmingham, Alabama
- Five Horizons Health Services — Montgomery, Alabama
- Five Horizons Health Services — Tuscaloosa, Alabama
- Five Horizons Health Services — Starkville, Mississippi
📞 Contact the Study Coordinator
Phone: (205) 934-9333
Email: mkempf@uab.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in HIV Prevention
- PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study) — Galveston, Texas
- Integrated HIV Prevention and HCV Care for PWID — Miami, Florida
- Clinic-based HIV Identification and Prevention Project Using Electronic Resources — Baltimore, Maryland
- Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW — Los Angeles, California
- Examining Migration, Social Bonds, Transnationalism, and HIV Prevention Pathways Among African Immigrants. — Buffalo, New York
- PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men — Miami, Florida
Explore by condition: All HIV Prevention clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.